InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,601.20
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.48
(
0.42%
)
Bitcoin
63,496.94
(
-0.78%
)
Post# of 251732
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119581
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 141824

Friday, 05/11/2012 5:23:29 PM

Friday, May 11, 2012 5:23:29 PM

Post# of 251732

ARNA—It's unclear to me what a REMS would look like for the Arena drug, or why one would even be needed.

Sounds like a good debate topic between you and jq, who thinks a REMS is obligatory (#msg-75487491).

Where do you weigh in on the chance of FDA approval on the current review cycle? T.i.a.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up